Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The Saccharomyces cerevisiae Sir2 protein is an NAD(+)-dependent histone deacetylase that plays a critical role in transcriptional silencing, genome stability, and longevity. A human homologue of Sir2, SIRT1, regulates the activity of the p53 tumor suppressor and inhibits apoptosis. The Sir2 deacetylation reaction generates two products: O-acetyl-ADP-ribose and nicotinamide, a precursor of nicotinic acid and a form of niacin/vitamin B(3). We show here that nicotinamide strongly inhibits yeast silencing, increases rDNA recombination, and shortens replicative life span to that of a sir2 mutant. Nicotinamide abolishes silencing and leads to an eventual delocalization of Sir2 even in G(1)-arrested cells, demonstrating that silent heterochromatin requires continual Sir2 activity. We show that physiological concentrations of nicotinamide noncompetitively inhibit both Sir2 and SIRT1 in vitro. The degree of inhibition by nicotinamide (IC(50) < 50 microm) is equal to or better than the most effective known synthetic inhibitors of this class of proteins. We propose a model whereby nicotinamide inhibits deacetylation by binding to a conserved pocket adjacent to NAD(+), thereby blocking NAD(+) hydrolysis. We discuss the possibility that nicotinamide is a physiologically relevant regulator of Sir2 enzymes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although NAM has been shown to be effective to increase NAD+ in tissues, it also exerts an inhibitory effect on sirtuin [88] and PARPs activity [89].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [88]
In the citing paper
“Deacetylation of PGC-1α is required to sequester it in the nucleus and this cellular redistribution is prevented by nicotinamide, a potent SIRT1 inhibitor [64].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [64]
Citations
Cites
Genomic Expression Programs in the Response of Yeast Cells to Environmental Changes
Gasch, A. P., Spellman, P. T., Kao, C. M., Carmel-Harel, O., Eisen, M. B., Storz, G., Botstein, D., & Brown, P. O. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4241 · Cited by 4,815
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Lin, S.-J., Defossez, P.-A., & Guarente, L. (2000) · Science · doi:10.1126/science.289.5487.2126 · Cited by 1,775
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
Extrachromosomal rDNA circles—a cause of aging in yeast
Sinclair, D. A., & Guarente, L. (1997) · Cell · doi:10.1016/s0092-8674(00)80493-6 · Cited by 1,500
Self-citationPosition effect at S. cerevisiae telomeres: Reversible repression of Pol II transcription
Gottschling, D. E., Aparicio, O. M., Billington, B. L., & Zakian, V. A. (1990) · Cell · doi:10.1016/0092-8674(90)90141-z · Cited by 1,345
Research works printed but not linked: 1
- Gasser, 1998, Novartis Found. Symp., 214, 114
Cited by
Items 501–600 of 1,000
Kim, W.-J., Lee, J.-W., Quan, C., Youn, H.-J., Kim, H.-M., & Bae, S.-C. (2011) · Journal of Urology · doi:10.1016/j.juro.2011.02.017 · Cited by 37
Suzuki, T., Imai, K., Imai, E., Iida, S., Ueda, R., Tsumoto, H., Nakagawa, H., & Miyata, N. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.001 · Cited by 39
Ye, D. Z., Tai, M.-H., Linning, K. D., Szabó, C., & Olson, L. K. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0653 · Cited by 39
Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform
Kolaj, I., Imindu Liyanage, S., & Weaver, D. F. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.001 · Cited by 39
“In plants, phenylpropanoids act as direct antioxidants, scavenging and quenching free radicals by donating protons or electrons from the phenol moiety (Bors et al., 1990; Sarkar et al., 2012).”
Mi, D., Fang, H., Zheng, G., Liang, X., Ding, Y., Liu, X., & Liu, L. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13042 · Cited by 42
Differential protein expression in the corpus callosum (genu) of human alcoholics
Kashem, M. A., Harper, C. G., & Matsumoto, I. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.04.003 · Cited by 39
“Sir-2 level was decreased by nicotinamide (Bitterman et al., 2002) and other small molecules including splitomicin (Gatbonton et al.”
Acetylation in pathogenesis: Revealing emerging mechanisms and therapeutic prospects
Jiang, N., Li, W., Jiang, S., Xie, M., & Liu, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115519 · Cited by 47
Youngson, N. A., Uddin, G. M., Das, A., Martinez, C., Connaughton, H. S., Whiting, S., Yu, J., Sinclair, D. A., Aitken, R. J., & Morris, M. J. (2019) · Reproduction · doi:10.1530/rep-18-0574 · Cited by 40
“NAM is known to inhibit sirtuins (Bitterman et al. 2002) which are required for normal spermatogenesis (Coussens et al. 2008).”
Self-citationBypassing Sir2 and O-Acetyl-ADP-Ribose in Transcriptional Silencing
Chou, C.-C., Li, Y., & Gartenberg, M. R. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.06.020 · Cited by 41
“Nicotinamide, a by-product of the Sir2 reaction, binds and inhibits the enzyme noncompetitively (Landry et al., 2000; Bitterman et al., 2002).”
Impact of ROS on ageing of two fungal model systems: Saccharomyces cerevisiae and Podospora anserina
Osiewacz, H. D., & Scheckhuber, C. Q. (2006) · Free Radical Research · doi:10.1080/10715760600921153 · Cited by 36
“[10] Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA.”
BackgroundCan targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review
Pulla, V. K., Battu, M. B., Alvala, M., Sriram, D., & Yogeeswari, P. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.703656 · Cited by 40
Reverter‐Branchat, G., Cabiscol, E., Tamarit, J., Sorolla, M. A., de la Torre-Ruiz, M. Á., & Ros, J. (2007) · Microbiology · doi:10.1099/mic.0.2007/009340-0 · Cited by 43
“This was carried out by measuring silencing in cells in which the URA3 reporter gene was located in the telomere, under Sir2p regulation. http://mic.sgmjournals.org 3673 Downloaded from www.microbiologyresearch.org by IP: 54.70.40.11 On: Fri, 25 Jan 2019 22:54:26 Duplication time was 20 % slower in the 26ADH1 strain,…”
MethodInfluentialProtection against telomeric position effects by the chicken cHS4 β-globin insulator
Rincón‐Arano, H., Furlan-Magaril, M., & Targa, F. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704999104 · Cited by 38
The oncoprotein gankyrin interacts with RelA and suppresses NF-κB activity
Higashitsuji, H., Higashitsuji, H., Liu, Y., Masuda, T., Fujita, T., Abdel-Aziz, H. I., Kongkham, S., Dawson, S. P., Mayer, R. J., Itoh, Y., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.072 · Cited by 38
“The enzymatic activities of HDACs in class I and II are inhibited by TSA, whereas those of class III are inhibited by nicotinamide but not TSA [9,11].”
BackgroundPaxman, J., Zhou, Z., O’Laughlin, R., Liu, Y., Li, Y., Tian, W., Su, H., Jiang, Y., Holness, S. E., Stasiowski, E., et al. (2022) · eLife · doi:10.7554/elife.75978 · Cited by 40
Nicotinamide mononucleotide as a therapeutic agent to alleviate multi-organ failure in sepsis
Cao, T., Ni, R., Ding, W., Ji, X., Fan, G., Zhang, Z., & Peng, T. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04767-3 · Cited by 40
“However, the use of niacin is limited by painful flushing, and nicotinamide may inhibit the SIRT family which is required for essential cellular functions [12, 13].”
Degtyareva, N. P., Saini, N., Sterling, J. F., Placentra, V. C., Klimczak, L. J., Gordenin, D. A., & Doetsch, P. W. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000263 · Cited by 40
Post-translational Acetylation Control of Cardiac Energy Metabolism
Ketema, E. B., & Lopaschuk, G. D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.723996 · Cited by 42
“Kinetics studies on sirtuins and NAD metabolites, have demonstrated the sensitivity of sirtuins to changes in nicotinamide and NAD levels, which inhibits and activates its enzymatic activity, respectively (58, 117, 118).”
BackgroundA quantitative high-throughput screen identifies potential epigenetic modulators of gene expression
Johnson, R. L., Huang, W., Jadhav, A., Austin, C. P., Inglese, J., & Martínez, E. D. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.12.028 · Cited by 37
“[PubMed: 11895880] [23].”
BackgroundYu, F., Wu, J., Chen, L., Luo, C., Shen, X., Chen, K., Jiang, H., & Liu, D. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.08.011 · Cited by 40
Feng, T., Liu, P., Wang, X., Luo, J., Zuo, X., Jiang, X., Liu, C., Li, Y., Li, N., Chen, M., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.04.039 · Cited by 35
McCarty, M. F., Luján, L. M. L., & Assanga, S. B. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094776 · Cited by 39
“Moreover, NAMPT induction not only boosts Sirt1 activity by increasing NAD+, but also by decreasing cellular levels of nicotinamide, a product of Sirt1 activity that acts as an end-protein inhibitor of this enzyme [116].”
BackgroundWang, W., Bai, L., Hu, Q., Li, Y., Yang, L., Zhang, J., Lin, R., Ren, F., Zhang, J., & Ji, M. (2013) · Inflammation · doi:10.1007/s10753-013-9728-6 · Cited by 40
“Sirtinol and NAM are the inhibitors of SIRT1 [14, 15].”
Catalysis and Mechanistic Insights into Sirtuin Activation
Dittenhafer‐Reed, K. E., Feldman, J. L., & Denu, J. M. (2010) · ChemBioChem · doi:10.1002/cbic.201000434 · Cited by 40
Activation and inhibition of sirtuins: From bench to bedside
Fiorentino, F., Fabbrizi, E., Mai, A., & Rotili, D. (2024) · Medicinal Research Reviews · doi:10.1002/med.22076 · Cited by 42
Sirtuins and Pyridine Nucleotides
Abdellatif, M. (2012) · Circulation Research · doi:10.1161/circresaha.111.246546 · Cited by 36
Dopamine Triggers CTCF-Dependent Morphological and Genomic Remodeling of Astrocytes
Galloway, A. L., Adeluyi, A., O’Donovan, B., Fisher, M. L., Rao, C. N., Critchfield, P., Sajish, M., Turner, J. R., & Ortinski, P. I. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3349-17.2018 · Cited by 41
“…for CTCF, commonly used NAD precursors, nicotinamide and nicotinamide riboside, exhibit opposite effects on PARP1 activity due to their disparate effects on SIRT1, the negative regulator of PARP1 (Bitterman et al., 2002; Rajamohan et al., 2009; Sajish and Schimmel, 2015; Trammell et al., 2016).”
BackgroundHu, Q., Tang, H., & Wang, Y. (2020) · Journal of Analysis and Testing · doi:10.1007/s41664-020-00126-z · Cited by 36
Biological Efficacy and Safety of Niacinamide in Patients With ADPKD
Ters, M. E., Zhou, X., Lepping, R. J., Lu, P., Karcher, R. T., Mahnken, J. D., Brooks, W. M., Winklhofer, F. T., Li, X., & Yu, A. S. L. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.06.002 · Cited by 37
Yang, D., Zhang, X., Yue, L., Hu, H., Wei, X., Guo, Q., Zhang, B., Fan, X., Xin, Y., Oh, Y., et al. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.129727 · Cited by 35
Oral nicotinamide: The role in skin cancer chemoprevention
Giacalone, S., Spigariolo, C. B., Bortoluzzi, P., & Nazzaro, G. (2021) · Dermatologic Therapy · doi:10.1111/dth.14892 · Cited by 35
“A recent study showed promising effect of NAM in silencing SIRT-1 gene trascription.(15)”
BackgroundInhibition of NAMPT pathway by FK866 activates the function of p53 in HEK293T cells
Thakur, B. K., Dittrich, T., Chandra, P., Becker, A., Lippka, Y., Selvakumar, D., Klusmann, J., Reinhardt, D., & Welte, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.075 · Cited by 40
Rat models of caloric intake and activity: relationships to animal physiology and human health
Young, G. S., & Kirkland, J. B. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-082 · Cited by 42
“Following feeding, levels of NAD+ decrease and levels of NADH increase, with the effect of inhibiting Sir activity (Bitterman et al. 2002).”
BackgroundColman, M. J. R., Reverter‐Branchat, G., Sorolla, M. A., Tamarit, J., Ros, J., & Cabiscol, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.174763 · Cited by 44
Characterization of CobB kinetics and inhibition by nicotinamide
Gallego‐Jara, J., Conesa, A. É., Puente, T. D. D., Terol, G. L., & Cánovas, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189689 · Cited by 37
Recent Advances in Inhibitors of Sirtuin1/2: An Update and Perspective
Zhou, Z., Ma, T., Zhu, Q., Xu, Y., & Zha, X. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0207 · Cited by 36
Chen, S., Fan, Q., Li, A., Liao, D., Ge, J., Laties, A. M., & Zhang, X. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0837-3 · Cited by 36
“inhibitors of this protein class so far [33].”
BackgroundKondo, T., Oue, N., Mitani, Y., Kuniyasu, H., Noguchi, T., Kuraoka, K., Nakayama, H., & Yasui, W. (2005) · Oncogene · doi:10.1038/sj.onc.1207832 · Cited by 38
“TSA inhibits class I and II deacetylases, whereas nicotinamide (NAM) inhibits hSir2 (Luo et al., 2001; Bitterman et al., 2002).”
BackgroundQin, R., Sang, Y., Ren, J., Zhang, Q., Li, S., Cui, Z., & Yao, Y. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01864 · Cited by 37
“The expression of the type 1 fimbriae can be evaluated by the yeast agglutination assay (Kukkonen et al., 1993; Baumler et al., 1997).”
MethodIndependent regulation of age associated fat accumulation and longevity
Beas, A. O., Gordon, P. B., Prentiss, C. L., Olsen, C. P., Kukurugya, M. A., Bennett, B. D., Parkhurst, S. M., & Gottschling, D. E. (2020) · Nature Communications · doi:10.1038/s41467-020-16358-7 · Cited by 33
Mitochondrial Metabolism and Aging in Yeast
Baccolo, G., Stamerra, G., Pellegrino-Coppola, D., Orlandi, I., & Vai, M. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.05.001 · Cited by 39
Kong, B. W. C., Man, R. Y. K., Gao, Y., Vanhoutte, P. M., & Leung, S. W. S. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.150 · Cited by 36
“Silent information regulator T1 (SIRT1) is an important regulator of the process of aging and cellular senescence (Bitterman et al. 2002; Ota et al. 2007; Donmez and Guarente 2010; Wang et al. 2011).”
Sirtuin Deacetylases as Therapeutic Targets in the Nervous System
Langley, B. C., & Sauve, A. A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0214-5 · Cited by 34
“Conversely, deletion of pnc1 caused loss of replicative lifespan and reduced gene silencing in heterochromatin, consistent with a negative effect on Sir2 catalytic function in yeast [91, 95, 96].”
Role of Sirtuins in Maintenance of Genomic Stability: Relevance to Cancer and Healthy Aging
Wu, X., Neng, C., Fenech, M. F., & Wang, X. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3280 · Cited by 34
Diabetes Mellitus: Channeling Care through Cellular Discovery
Maiese, K., Shang, Y., Chong, Z. Z., & Hou, J. (2010) · Current Neurovascular Research · doi:10.2174/156720210790820217 · Cited by 34
Identification and characterization of novel sirtuin inhibitor scaffolds
Sanders, B. D., Jackson, B. A., Brent, M. M., Taylor, A. M., Dang, W., Berger, S. L., Schreiber, S. L., Howitz, K. T., & Marmorstein, R. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.073 · Cited by 35
Crystal structure of the yeast nicotinamidase Pnc1p
Hu, G., Taylor, A. B., McAlister-Henn, L., & Hart, P. J. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.01.037 · Cited by 36
“These levels are similar to those that produce inhibition of Sir2p [IC50 values of 50–120 μM [4;8]] Furthermore, exogenous addition of nicotinamide has been shown to inhibit Sir2p-dependent silencing and to reduce life span in yeast [4;5;39], whereas exogenous addition of isonicotinamide, an antagonist of nicotinamide…”
BackgroundShan, T., Ren, Y., & Wang, Y. (2013) · Journal of Animal Science · doi:10.2527/jas.2011-5030 · Cited by 36
“Nicotinamide is a strong noncompetitive inhibitor of Sirt1 and has recently been shown to inhibit Sirt1 activity both in vivo and in vitro (Bitterman et al., 2002; Jackson et al., 2003).”
BackgroundMelanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?
Minocha, R., Damian, D. L., & Halliday, G. M. (2017) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.12328 · Cited by 32
Nampt expression increases during osteogenic differentiation of multi- and omnipotent progenitors
Li, Y., He, J., He, X., Li, Y., & Lindgren, U. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.132 · Cited by 31
Global Profiling of 2-Hydroxyisobutyrylome in Common Wheat
Zhang, N., Zhang, L., Li, L., Geng, J., Zhao, L., Ren, Y. N., Dong, Z., & Chen, F. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.06.008 · Cited by 39
“For these activities, trichostatin (TSA) is an inhibitor of HDAC I and II [53], and nicotinamide (NAM) is an inhibitor for SIRT family deacetylases [54,55].”
BackgroundRegulation of cellular homoeostasis by reversible lysine acetylation
Scott, I. (2012) · Essays in Biochemistry · doi:10.1042/bse0520013 · Cited by 33
“Secondly, one of the by-products of the NAD+-dependent sirtuin deacetylation reaction is NAM (nicotinamide), which acts as an inhibitor of sirtuins [12].”
BackgroundDong, W.-R., Sun, C.-C., Zhu, G., Hu, S.-H., Xiang, L., & Shao, J. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-29 · Cited by 34
“Since NAM is also known as a strong inhibitor of several NAD (P)-consuming enzymes, uncontrolled NAM accumulation may negatively affect not only NAD metabolism, but also cellular functions such as gene silencing, Hst1mediated transcriptional repression, and life span of cells [31-34].”
BackgroundPorcine sirtuin 1 gene clone, expression pattern, and regulation by resveratrol1
Shan, T., Wang, Y., Wu, T., Liu, C., Guo, J., Zhang, Y., Liu, J., & Xu, Z. (2008) · Journal of Animal Science · doi:10.2527/jas.2008-1344 · Cited by 33
“Sirtuin 1 is regulated by nutritional status (Bordone and Guarente, 2005; Moynihan and Imai, 2006) and by other factors such as nicotinamide, sirtinol, and splitomicin (Bedalov et al., 2001; Bitterman et al., 2002; Araki et al., 2004).”
BackgroundXie, Y., Zhang, J., Xu, Y., & Shao, C. (2012) · Journal of Radiation Research · doi:10.1269/jrr.11062 · Cited by 33
Orozco, H., Matallana, E., & Aranda, A. (2012) · Microbial Cell Factories · doi:10.1186/1475-2859-11-104 · Cited by 34
“During the reaction, it produces nicotinamide, which acts as an inhibitor of its deacetylase activity [17].”
BackgroundSkokowa, J., & Welte, K. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04963.x · Cited by 32
Wu, R., Zhang, F., Liu, L., Li, W., Pichersky, E., & Wang, G. (2018) · Molecular Plant · doi:10.1016/j.molp.2018.07.003 · Cited by 30
Liu, J., Li, K., Yi, Z., Saqirile, Wang, C., & Yang, R. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080614 · Cited by 36
A ride through the epigenetic landscape: aging reversal by reprogramming
Camillo, L. P. D. L., & Quinlan, R. B. A. (2021) · GeroScience · doi:10.1007/s11357-021-00358-6 · Cited by 32
“On the other hand, nicotinamide, a SIRT1 inhibitor, promotes reprogramming at the same concentration it reduces yeast replicative lifespan [191, 216].”
BackgroundCapella, M., Mandemaker, I. K., Caballero, L. M., den Brave, F., Pfander, B., Ladurner, A. G., Jentsch, S., & Braun, S. J. (2021) · Nature Communications · doi:10.1038/s41467-021-25205-2 · Cited by 30
McClure, J. M., Wierman, M. B., Maqani, N., & Smith, J. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.367524 · Cited by 33
“Another NAD precursor, NAM, shares a functional property of INAM in its ability to raise the NAD concentration in yeast (38), although it acts as a strong sirtuin inhibitor (22).”
BackgroundGu, J., Deng, J.-Y., Li, R., Wei, H., Zhang, Z., Zhou, Y., Zhang, Y., & Zhang, X. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909070062 · Cited by 32
Nicotinamide extends the replicative life span of primary human cells
Lim, C., Potts, M., & Helm, R. F. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.02.001 · Cited by 30
Nicotinamide: a Class III HDACi Delays In Vitro Aging of Mouse Oocytes
Lee, A. R., Kishigami, S., Amano, T., Matsumoto, K., Wakayama, T., & Hosoi, Y. (2013) · Journal of Reproduction and Development · doi:10.1262/jrd.2012-171 · Cited by 33
“yeast grown in the presence of added NAM causes defects in Sir2mediated transcriptional silencing, increasing rDNA recombination, and a significantly shorter lifespan [23].”
BackgroundShibata, K. (2018) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.64.90 · Cited by 30
Oppedisano, F., Nesci, S., & Spagnoletta, A. (2024) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2024.2377094 · Cited by 29
Joo, S.-Y., Aung, J. M., Shin, M., Moon, E., Kong, H.-H., Goo, Y., Chung, D.-I., & Hong, Y. (2020) · Parasites & Vectors · doi:10.1186/s13071-020-04237-5 · Cited by 29
Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
Magalhães, J. D., Fão, L., Vilaça, R., Cardoso, S. M., & Rego, A. C. (2021) · Biomedicines · doi:10.3390/biomedicines9111625 · Cited by 30
“Despite potential beneficial effects, nicotinamide that is released from nicotinamide adenine dinucleotide (NAD+, a nucleotide required for sirtuins activity) during the deacylation reaction of sirtuins was shown to act as a non-competitive inhibitor [360] and thus may abrogate neuroprotective effects exerted by these…”
BackgroundOdoh, C. K., Guo, X., Arnone, J. T., Wang, X., & Zhao, Z. K. (2022) · Biogerontology · doi:10.1007/s10522-022-09958-x · Cited by 30
“For instance, NAM could function as both NAD precursor and an inhibitor of NAD dependent enzymes, such as the sirtuins (Jackson et al. 2003; Bitterman et al. 2002).”
BackgroundRegulation of SIRT1 in Ovarian Function: PCOS Treatment
Li, X., He, Y., Wu, S., Zhang, P., Gan, M., Chen, L., Zhao, Y., Niu, L., Zhang, S., Jiang, Y., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45030133 · Cited by 34
Maiese, K. (2023) · Cells · doi:10.3390/cells12222595 · Cited by 31
“Yet , concentrations of cellular nicotinamide should always be considered since elevated levels of nicotinamide can decrease SIRT1 activity [517] and may conceivably reduce protection for cells during oxidative stress through the loss of SIRT1.”
BackgroundSenescence suppressors: their practical importance in replicative lifespan extension in stem cells
Hwang, E. S. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1685-1 · Cited by 32
“SIRT1 [73, 74].”
Kato, M., & Lin, S.-J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.558643 · Cited by 31
Sirtuin biology and relevance to diabetes treatment
Dong, X. C. (2012) · Diabetes Management · doi:10.2217/dmt.12.16 · Cited by 30
Cellular lifespan and senescence: a complex balance between multiple cellular pathways
Dolivo, D., Hernandez, S. J., & Dominko, T. (2016) · BioEssays · doi:10.1002/bies.201670906 · Cited by 32
Xu, J., & Hershman, J. M. (2006) · Thyroid · doi:10.1089/thy.2006.16.151 · Cited by 29
“Nicotinamide, a fa-vorite substrate of NNMT, was reported to be an inhibitor of the NAD (cid:1) -dependent histone/protein deacetylases, such as Sir2 (yeast) and SIRT1 (human) (3).”
The Theoretical Basis of Transcriptional Therapy of Cancer: Can It Be Put Into Practice?
Melnick, A. M., Adelson, K. B., & Licht, J. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.498 · Cited by 29
Nicotinamide N -Methyltransferase in Health and Cancer
Ramsden, D. B., Waring, R. H., Barlow, D. J., & Parsons, R. B. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917691739 · Cited by 29
Recent advances in the development of histone deacylase SIRT2 inhibitors
Yang, W., Chen, W., Su, H., Li, R., Song, C., Wang, Z., & Yang, L. (2020) · RSC Advances · doi:10.1039/d0ra06316a · Cited by 28
Cros, C. D., Margier, M., Cannelle, H., Charmetant, J., Hulo, N., Laganier, L., Grozio, A., & Canault, M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.895028 · Cited by 31
“…and immune dysregulation in sepsis (Zeden et al., 2010; Changsirivathanathamrong et al., 2011; Darcy et al., 2011), and the use of nicotinamide to generate NAD+ via NAMPT is limited by its inhibitory function on Sirtuins (Bitterman et al., 2002) and side effects (Bogan and Brenner, 2008).”
BackgroundLinke, C., Klipp, E., Lehrach, H., Barberis, M., & Krobitsch, S. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00173 · Cited by 32
“Moreover, Fkh transcription factors might help to recruit Sir2 and other HDACs to maintain genome stability, consistently with previous studies demonstrating that Sir2 silences heterochromatin structures like telomeres, nucleolar rDNA, and mating type loci (Bitterman et al., 2002).”
BackgroundEpigenetic enzymes: A role in aging and prospects for pharmacological targeting
PASYUKOVA, E. G., Symonenko, A. V., Rybina, O. Y., & Vaiserman, A. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101312 · Cited by 29
Aneuploidy and Improved Growth Are Coincident but Not Causal in a Yeast Cancer Model
Li, X. C., Schimenti, J. C., & Tye, B. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000161 · Cited by 27
“To test whether the Igp is due to epigenetic modifications such as histone H3 and H4 lysine deacetylation, we treated wild-type G1-1-F1 and G1-1-N1 with histone deacetylase inhibitors: the histone deacetylase inhibitors nicotinamide (NAM) and Trichostatin A (TSA), repressing nicotinamide adenine dinucleotide (NAD)-dep…”
MethodGomes, P., Leal, H., Mendes, A. F., Reis, F., & Cavadas, C. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.09.003 · Cited by 28
NAD+ Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease
Chanvillard, L., Tammaro, A., & Sorrentino, V. (2022) · Cells · doi:10.3390/cells12010021 · Cited by 29
“Interestingly, NAM non-competitively binds and thus feedback-inhibits sirtuins at least in the simple model Saccharomyces cerevisiae, underscoring the importance of NAD+ metabolites fluxes in cells [83,84].”
BackgroundHow do K-RAS-activated cells evade cellular defense mechanisms?
Lee, Y.-S., & Bae, S.-C. (2015) · Oncogene · doi:10.1038/onc.2015.153 · Cited by 27
A Global Perspective of the Genetic Basis for Carbonyl Stress Resistance
Hoon, S. S., Gebbia, M., Costanzo, M., Davis, R. W., Giaever, G. N., & Nislow, C. (2011) · G3 Genes Genomes Genetics · doi:10.1534/g3.111.000505 · Cited by 30
“Therefore, we mimicked activation of Sir2 using isonicotinamide to amplify the sensitivity of the MSP screen (Figure 3B).”
Microplate filtration assay for nicotinamide release from NAD using a boronic acid resin
McDonagh, T., Hixon, J., DiStefano, P. S., Curtis, R., & Napper, A. D. (2005) · Methods · doi:10.1016/j.ymeth.2005.03.005 · Cited by 31
H4K16 acetylation affects recombination and ncRNA transcription at rDNA inSaccharomyces cerevisiae
Cesarini, E., D’Alfonso, A., & Camilloni, G. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0095 · Cited by 27
“First, we analyzed WT cells treated with 500 μM nicotinamide (NAM), a sirtuin noncompetitive inhibitor that increases rDNA recombination and shortens replicative lifespan (Bitterman et al., 2002).”
BackgroundMethodNatural Products and Chemical Biology Tools: Alternatives to Target Epigenetic Mechanisms in Cancers
Lascano, S., Lopez, M., & Arimondo, P. B. (2018) · The Chemical Record · doi:10.1002/tcr.201800133 · Cited by 27
Huang, P.-S., Son, J., Abbott, L. C., & Winzer‐Serhan, U. H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.007 · Cited by 29
In vitro activity of nicotinamide/antileishmanial drug combinations
Gazanion, É., Vergnes, B., Seveno, M., Garcia, D., Oury, B., Aït-Oudhia, K., Ouaissi, A., & Séréno, D. (2010) · Parasitology International · doi:10.1016/j.parint.2010.09.005 · Cited by 27
“Among cellular targets of nicotinamide, it has been demonstrated that NAm inhibits the enzymatic activity of NAD-consuming enzymes, such as SIR2 NADdependent histone deacetylases [11,28].”
BackgroundYeast as a model for ageing and apoptosis research
Breitenbach, M., Madeo, F., Laun, P., Heeren, G., Jarolim, S., Fröhlich, K., Wissing, S., & Pichová, A. (2003) · Topics in current genetics · doi:10.1007/978-3-540-37005-5_4 · Cited by 31
“It is highly conserved in eukaryotic cells and its involvement in ageing (and cancer) is being actively investigated presently ( Bitterman et al. 2002; Rogina et al. 2002).”
BackgroundEpigenetics in BIOLOGY and MEDICINE
(2008) · CRC Press eBooks · doi:10.1201/9781420007077 · Cited by 27
Metabolic modulation of chromatin: implications for DNA repair and genomic integrity
Liu, J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00182 · Cited by 27
Genetic Control of Genomic Alterations Induced in Yeast by Interstitial Telomeric Sequences
Moore, A., Dominska, M., Greenwell, P. W., Aksenova, A. Y., Mirkin, S. M., & Petes, T. D. (2018) · Genetics · doi:10.1534/genetics.118.300950 · Cited by 26
“These strains were Trp2 on standard omission medium, but Trp+ on medium lacking tryptophan but containing nicotinamide; nicotinamide is a drug that reverses silencing induced by telomeric repeats (Bitterman et al. 2002).”
BackgroundAdvances in quantitative biology methods for studying replicative aging in Saccharomyces cerevisiae
O’Laughlin, R., Jin, M., Li, Y., Pillus, L., Tsimring, L. S., Hasty, J., & Hao, N. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.09.002 · Cited by 26
Ashimori, A., Nakahata, Y., Sato, T., Fukamizu, Y., Matsui, T., Yoshitane, H., Fukada, Y., Shinohara, K., & Bessho, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.647589 · Cited by 27
Metadata
- Authors
- Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Sinclair, David A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 47
- Pages
- 45099-45107
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2167990179
- Cited by
- 1,002
- References
- 66
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 32 · 2023: 33 · 2022: 36 · 2021: 41 · 2020: 38 · 2019: 39 · 2018: 47 · 2017: 43 · 2016: 43 · 2015: 58 · 2014: 40 · 2013: 58 · 2012: 56
- FWCI
- 21.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6554 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG11972-01)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- nicotinamide, Sir2, SIRT1, transcriptional silencing, heterochromatin, replicative lifespan, aging, NAD+ hydrolysis, enzyme inhibition, p53, apoptosis, histone deacetylation
- MeSH terms
- Aging, DNA, Ribosomal, Genes, Fungal, Histone Deacetylases, Humans, Life Expectancy, Luminescent Proteins, Models, Biological, Niacinamide, Recombinant Fusion Proteins, Recombination, Genetic, Saccharomyces cerevisiae, Molecular Structure, Telomere, Gene Silencing, Sirtuins, Silent Information Regulator Proteins, Saccharomyces cerevisiae, Green Fluorescent Proteins, Sirtuin 1, Sirtuin 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.